DOI QR코드

DOI QR Code

A New Flow-Diverter (the FloWise): In-Vivo Evaluation in an Elastase-Induced Rabbit Aneurysm Model

  • Kim, Byung Moon (Severance Integrated Research Institute of Cerebrovascular Disease, Yonsei University College of Medicine) ;
  • Kim, Dong Joon (Severance Integrated Research Institute of Cerebrovascular Disease, Yonsei University College of Medicine) ;
  • Kim, Dong Ik (Severance Integrated Research Institute of Cerebrovascular Disease, Yonsei University College of Medicine)
  • Received : 2015.06.25
  • Accepted : 2015.10.26
  • Published : 2016.02.01

Abstract

Objective: We aimed to evaluate the efficacy and safety of a newly developed, partially retrievable flow-diverter (the FloWise) in an elastase-induced rabbit aneurysm model. Materials and Methods: We developed a partially retrievable flow diverter composed of 48 strands of Nitinol and platinum wire. The FloWise is compatible with any microcatheter of 0.027-inch inner diameter, and is retrievable up to 70% deployment. The efficacy and safety of the FloWise were evaluated in the elastase-induced rabbit aneurysm model. The rate of technical success (full coverage of aneurysm neck) and assessment of aneurysm occlusion and stent patency was conducted by angiograms and histologic examinations at the 1-month, 3-month, and 6-month follow-up. The patency of small arterial branches (intercostal or lumbar arteries) covered by the FloWise were also assessed in the 5 subjects. Results: We attempted FloWise insertion in a total of 32 aneurysm models. FloWise placement was successful in 31 subjects (96.9%). Two stents (6.2%) were occluded at the 3-month follow-up, but there was no evidence of in-stent stenosis in other subjects. All stented aneurysms showed progressive occlusion: grade I (complete aneurysm occlusion) in 44.4% and grade II (aneurysm occlusion > 90%) in 55.6% at 1 month; grade I in 90% and II in 10% at 3 months; and grade I in 90% and II in 10% at 6 months. All small arterial branches covered by the FloWise remained patent. Conclusion: A newly developed, partially retrievable flow-diverter seems to be a safe and effective tool of aneurysm occlusion, as evaluated in the rabbit aneurysm model.

Keywords

Acknowledgement

Supported by : Korea Health Industry Development Institute (KHIDI)

References

  1. Altes TA, Cloft HJ, Short JG, DeGast A, Do HM, Helm GA, et al. 1999 ARRS Executive Council Award. Creation of saccular aneurysms in the rabbit: a model suitable for testing endovascular devices. American Roentgen Ray Society. AJR Am J Roentgenol 2000;174:349-354 https://doi.org/10.2214/ajr.174.2.1740349
  2. Krings T, Moller-Hartmann W, Hans FJ, Thiex R, Brunn A, Scherer K, et al. A refined method for creating saccular aneurysms in the rabbit. Neuroradiology 2003;45:423-429 https://doi.org/10.1007/s00234-003-0976-2
  3. Kallmes DF, Ding YH, Dai D, Kadirvel R, Lewis DA, Cloft HJ. A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke 2007;38:2346-2352 https://doi.org/10.1161/STROKEAHA.106.479576
  4. Kallmes DF, Ding YH, Dai D, Kadirvel R, Lewis DA, Cloft HJ. A second-generation, endoluminal, flow-disrupting device for treatment of saccular aneurysms. AJNR Am J Neuroradiol 2009;30:1153-1158 https://doi.org/10.3174/ajnr.A1530
  5. Lylyk P, Miranda C, Ceratto R, Ferrario A, Scrivano E, Luna HR, et al. Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience. Neurosurgery 2009;64:632-642; discussion 642-643; quiz N6 https://doi.org/10.1227/01.NEU.0000339109.98070.65
  6. Lubicz B, Collignon L, Raphaeli G, Pruvo JP, Bruneau M, De Witte O, et al. Flow-diverter stent for the endovascular treatment of intracranial aneurysms: a prospective study in 29 patients with 34 aneurysms. Stroke 2010;41:2247-2253 https://doi.org/10.1161/STROKEAHA.110.589911
  7. Tahtinen OI, Manninen HI, Vanninen RL, Seppanen J, Niskakangas T, Rinne J, et al. The silk flow-diverting stent in the endovascular treatment of complex intracranial aneurysms: technical aspects and midterm results in 24 consecutive patients. Neurosurgery 2012;70:617-623; discussion 623-624 https://doi.org/10.1227/NEU.0b013e31823387d4
  8. Yu SC, Kwok CK, Cheng PW, Chan KY, Lau SS, Lui WM, et al. Intracranial aneurysms: midterm outcome of pipeline embolization device--a prospective study in 143 patients with 178 aneurysms. Radiology 2012;265:893-901 https://doi.org/10.1148/radiol.12120422
  9. Brinjikji W, Murad MH, Lanzino G, Cloft HJ, Kallmes DF. Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke 2013;44:442-447 https://doi.org/10.1161/STROKEAHA.112.678151
  10. Becske T, Kallmes DF, Saatci I, McDougall CG, Szikora I, Lanzino G, et al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology 2013;267:858-868 https://doi.org/10.1148/radiol.13120099

Cited by

  1. A Novel Flow Diverter (Tubridge) for the Treatment of Recurrent Aneurysms: A Single-Center Experience vol.18, pp.5, 2017, https://doi.org/10.3348/kjr.2017.18.5.852
  2. Update on flow diverters for the endovascular management of cerebral aneurysms vol.42, pp.6, 2017, https://doi.org/10.3171/2017.3.focus16427
  3. Update on flow diverters for the endovascular management of cerebral aneurysms vol.42, pp.6, 2017, https://doi.org/10.3171/2017.3.focus16427
  4. A Newly-Developed Flow Diverter (FloWise) for Internal Carotid Artery Aneurysm: Results of a Pilot Clinical Study vol.20, pp.3, 2019, https://doi.org/10.3348/kjr.2018.0421
  5. Tissue-engineered aneurysm models for in vitro assessment of neurovascular devices vol.61, pp.6, 2016, https://doi.org/10.1007/s00234-019-02197-x
  6. An Effective and Simple Way to Establish Elastase-Induced Middle Carotid Artery Fusiform Aneurysms in Rabbits vol.2020, pp.None, 2016, https://doi.org/10.1155/2020/6707012
  7. Promoting endothelialization of flow-diverting stents: a review vol.13, pp.1, 2016, https://doi.org/10.1136/neurintsurg-2020-015874